UroGen Pharma
URGN
URGN
65 hedge funds and large institutions have $109M invested in UroGen Pharma in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 25 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 25
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
65
Holding in Top 10
1
Calls
–
Puts
$1K
Top Buyers
| 1 | +$6.9M | |
| 2 | +$3.76M | |
| 3 | +$3.12M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.96M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.12M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$3.38M | |
| 3 | -$1.57M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.32M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.15M |